Baseline neutrophil-to-lymphocyte ratio and PD-L1 expression level or LDH value may predict outcome of patients with high PD-L1 advanced non-small cell lung cancer treated with first-line pembrolizumab

Lung Cancer ◽  
2020 ◽  
Vol 139 ◽  
pp. S58-S59
Author(s):  
G. Banna ◽  
D. Signorelli ◽  
G. Metro ◽  
D. Galetta ◽  
A. De Toma ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Neutrophil To Lymphocyte Ratio ◽  
Expression Level ◽  
Small Cell Lung ◽  
First Line ◽  
Lymphocyte Ratio ◽  
Ldh Value

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Lung Cancer ◽  
2017 ◽  
Vol 106 ◽  
pp. 1-7 ◽  
Author(s):  
Stephen J. Bagley ◽  
Shawn Kothari ◽  
Charu Aggarwal ◽  
Joshua M. Bauml ◽  
Evan W. Alley ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Neutrophil To Lymphocyte Ratio ◽  
Small Cell Lung ◽  
Lymphocyte Ratio
Sign in / Sign up

Export Citation Format

Share Document